Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III trial of bencycloquidium bromide nasal spray for common cold nasal symptoms
CTR20211344Phase 3Active
- Sponsor
- Beijing Yingu Century Pharmaceutical
- Start
- Sep 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Bencycloquidium bromide in nasopharyngitis, sponsored by Beijing Yingu Century Pharmaceutical. Started Sep 2021; status: active.
02
Drugs
Bencycloquidium bromide
03
Conditions
nasopharyngitis
Beyond the preview
Go deeper on CTR20211344.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20211344.